INVENTA MEDICAL UK LIMITEDActive

Company number 11094679Private limited companyIncorporated 2017

Key figures

£688-13.5%
Net assets 2025
-38.1%
Average annual change 2020–2025
02 k4 k6 k8 k202020212022202320242025

Like most small UK companies, INVENTA MEDICAL UK LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
010 k20 k202020212022202320242025

Dividends

from the accounts
2020

Dividends paid in the financial year: £15,000 (116% of the profit for the year).

Filed accounts2020–2025
20212022202320242025
Profit for the year-4,315-777-563-1,142—
Cash at bank and in hand12604563148
Total assets7,8456,8235,1333,001—
Total liabilities2,8743,1862,0591,648—
Net assets / total equity3,2772,5001,937795688
Average number of employees22220
Dividends paid—————

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: INVENTA MEDICAL UK LIMITED

Company

INVENTA MEDICAL UK LIMITED is a private limited company registered with Companies House under company number 11094679. It was incorporated on 4 Dec 2017. Its status is active. The registered office is in Shrewsbury (SY2). Its nature of business (SIC 2007) is retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c. (47749), other information service activities n.e.c. (63990).

Accounts

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts (filleted). Net assets were £688, down 13.5% on the previous year. Cash at bank and in hand was £148. The company had an average of 0 employees. Figures are available for 6 financial years (2020–2025).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 17 Dec 2026.